Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 6, 2013, Pages 826-833

  Abrahamson, Eric E ^a,b   Foley, Lesley M ^c   Dekosky, Steven T ^d   Kevin Hitchens, T ^c   Ho, Chien ^c   Kochanek, Patrick M ^a,e   Ikonomovic, Milos D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Amyloid; Arterial spin labeling MRI; Blood flow; Brain injury; Statin

Indexed keywords

AMYLOID BETA PROTEIN; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HYPEREMIA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIN LABELING; TRANSGENIC MOUSE; TRAUMATIC BRAIN INJURY; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTICHOLESTEREMIC AGENTS; BRAIN; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; GENE KNOCK-IN TECHNIQUES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RISK FACTORS; SIMVASTATIN;

EID: 84878570787     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.24     Document Type: Article

References (37)

1. Van Den Heuvel C, Thornton E, Vink R. Traumatic brain injury and Alzheimer's disease: a review. Prog Brain Res 2007; 161: 303-316.
2. Kelly DF, Martin NA, Kordestani R, Counelis G, Hovda DA, Bergsneider M et al. Cerebral blood flow as a predictor of outcome following traumatic brain injury. J Neurosurg 1997; 86: 633-641.
3. Iadecola C. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia. Cell Mol Neurobiol 2003; 23: 681-689.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
5. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI. B amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psych 1994; 57: 419-425.
6. Ikonomovic MD, Uryu K, Abrahamson EE, Ciallella JR, Trojanowski JQ, VM-Y Lee et al. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp Neurol 2004; 190: 192-203.
7. DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RSB et al. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol 2007; 64: 541-544.
8. Smith DH, Nakamura M, McIntosh TK, Wang J, Rodriguez A, Chen X-H et al. Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 1998; 153: 1005-1010.
9. Abrahamson EE, Ikonomovic MD, Ciallella JR, Hope CE, Paljug WR, Isanski BA et al. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: Implications for clinical outcome. Exp Neurol 2006; 197: 437-450.
10. Abrahamson EE, Ikonomovic MD, Dixon CE, DeKosky ST. Simvastatin therapy prevents brain trauma-induced elevations in b-amyloid peptide levels. Ann Neurol 2009; 66: 407-414.
11. Loane DJ, Pocivavsek A, Moussa CE, Thompson R, Matsuoka Y, Faden AI et al. Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat Med 2009; 15: 377-379.
12. Loane D, Washington P, Vardanian L, Pocivavsek A, Hoe HS, Duff KE et al. Modulation of ABCA1 by an LXR agonist reduces b-amyloid levels and improves outcome after traumatic brain injury. J Neurotrauma 2011; 28: 225-236.
13. Crawford F, Suo Z, Fang C, Mullan M. Characteristics of the in vitro vasoactivity of beta-amyloid peptides. Exp Neurol 1998; 150: 159-168.
14. Suo Z, Humphrey J, Kundtz A, Sethi F, Placzek A, Crawford F et al. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo. Neurosci Lett 1998; 257: 77-80.
15. Dietrich HH, Xiang C, Han BH, Zipfel GJ, Holtzman DM. Soluble amyloidbeta, effect on cerebral arteriolar regulation and vascular cells. Mol Neurodegen 2010; 5: 15.
16. DeKosky ST, Ikonomovic MD, Gandy S. Traumatic brain injury: football, warfare, and long-term effects. N Engl J Med. 2010; 363: 1293-1296.
17. Jain KK. Neuroprotection in traumatic brain injury. Drug Discov Today 2008; 13: 1082-1089.
18. Wible EF, Laskowitz DT. Statins in traumatic brain injury. Neurotherapeutics 2010; 7: 62-73.
19. Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R et al. Simvastatin improves cerebrovascular function and counters soluble amyloidbeta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis 2009; 35: 406-414.
20. Tong XK, Lecrux C, Rosa-Neto P, Hamel E. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J Neurosci 2012; 32: 4705-4715.
21. Reaume AG, Howland DS, Trusko SP, Savage MJ, Lang DM, Greenberg BD et al. Enhanced amyloidogenic processing of the b-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Ab sequence. J Biol Chem 1996; 271: 23380-23388.
22. Foley LM, Hitchens TK, Melick JA, Bayir H, Ho C, Kochanek PM. Effect of inducible nitric oxide synthase on cerebral blood flow after experimental traumatic brain injury in mice. J Neurotrauma 2008; 25: 299-310.
23. Franklin KBJ, Paxinos G (eds). The mouse brain in stereotaxic coordinates. Academic Press: San Diego, CA, 1997.
24. Tsujimoto Y. Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes. Cell Death Differ 1997; 4: 429-434.
25. Bullock R, Sakas D, Patterson J, Wyper D, Hadley D, Maxwell W et al. Early posttraumatic cerebral blood flow mapping: correlation with structural damage after focal injury. Acta Neurochir Suppl 1992; 55: 14-17.
26. Biagas KV, Grundl PD, Kochanek PM, Schiding JK, Nemoto EM. Posttraumatic hyperemia in immature, mature, and aged rats: autoradiographic determination of cerebral blood flow. J Neurotrauma 1996; 13: 189-200.
27. Park L, Anrather J, Forster C, Kazama K, Carlson GA, Iadecola C. Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex. J Cereb Blood Flow Metab 2004; 24: 334-342.
28. Townsend KP, Obregon D, Quadros A, Patel N, Volmar C, Paris D et al. Proinflammatory and vasoactive effects of Abeta in the cerebrovasculature. Ann N Y Acad Sci 2002; 977: 65-76.
29. Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 2004; 366: 80-85.
30. Niwa K, Younkin L, Ebeling C, Turner SK, Westaway D, Younkin S et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci USA 2000; 97: 9735-9740.
31. Wang H, Lynch JR, Song P, Yang HJ, Yates RB, Mace B et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 2007; 206: 59-69.
32. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998; 95: 8880-8885.
33. Nagaoka T, Hein TW, Yoshida A, Kuo L. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways. Invest Ophthalmol Vis Sci 2007; 48: 825-832.
34. Laufs U, Liao JK. Direct vascular effects of HMG-CoA reductase inhibitors. Trends Cardiovasc Med 2000; 10: 143-148.
35. Wu H, Jiang H, Lu D, Qu C, Xiong Y, Zhou D et al. Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury. Neurosurgery 2011; 68: 1363-1371.
36. Li B, Mahmood A, Lu D, Wu H, Xiong Y, Qu C et al. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury. Neurosurgery 2009; 65: 179-185.
37. Mannix RC, Whalen MJ. Traumatic brain injury, microglia, and Beta amyloid. Int J Alzheimers Dis 2012; 2012: 608732.